chr3-183825417-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_024871.4(MAP6D1):c.131G>A(p.Gly44Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000192 in 1,440,064 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_024871.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MAP6D1 | NM_024871.4 | c.131G>A | p.Gly44Asp | missense_variant | 1/3 | ENST00000318631.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MAP6D1 | ENST00000318631.8 | c.131G>A | p.Gly44Asp | missense_variant | 1/3 | 1 | NM_024871.4 | P1 | |
MAP6D1 | ENST00000431348.1 | c.131G>A | p.Gly44Asp | missense_variant | 1/3 | 2 | |||
MAP6D1 | ENST00000445426.1 | c.107G>A | p.Gly36Asp | missense_variant, NMD_transcript_variant | 1/3 | 4 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 151550Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000109 AC: 6AN: 55066Hom.: 0 AF XY: 0.000154 AC XY: 5AN XY: 32366
GnomAD4 exome AF: 0.000200 AC: 258AN: 1288514Hom.: 0 Cov.: 30 AF XY: 0.000191 AC XY: 121AN XY: 634400
GnomAD4 genome AF: 0.000125 AC: 19AN: 151550Hom.: 0 Cov.: 33 AF XY: 0.000108 AC XY: 8AN XY: 74034
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 05, 2023 | The c.131G>A (p.G44D) alteration is located in exon 1 (coding exon 1) of the MAP6D1 gene. This alteration results from a G to A substitution at nucleotide position 131, causing the glycine (G) at amino acid position 44 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at